Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- mental depression 18 Treffer
- pharmaceutical industry 18 Treffer
- clinical trials 13 Treffer
- drug approval 12 Treffer
- drug efficacy 12 Treffer
-
45 weitere Werte:
- united states. food & drug administration 10 Treffer
- bipolar disorder 8 Treffer
- multiple sclerosis 7 Treffer
- astrazeneca plc 6 Treffer
- h. lundbeck a/s 6 Treffer
- pain management 6 Treffer
- pharmaceutical research 6 Treffer
- antidepressants 5 Treffer
- placebos 5 Treffer
- clinical drug trials 4 Treffer
- forest laboratories inc. 4 Treffer
- shire plc 4 Treffer
- alzheimer's disease treatment 3 Treffer
- american psychiatric association 3 Treffer
- antipsychotic agents 3 Treffer
- attention-deficit disorder in adults 3 Treffer
- attention-deficit hyperactivity disorder 3 Treffer
- central nervous system diseases 3 Treffer
- drug development 3 Treffer
- drug dosage 3 Treffer
- medical research 3 Treffer
- targacept inc. 3 Treffer
- alzheimer's disease 2 Treffer
- analgesics 2 Treffer
- annual meetings 2 Treffer
- biogen inc. (2003- ) 2 Treffer
- biopharmaceutics 2 Treffer
- conferences & conventions 2 Treffer
- drug side effects 2 Treffer
- elan corp. plc 2 Treffer
- eli lilly & co. 2 Treffer
- glaxosmithkline 2 Treffer
- medical experimentation on humans 2 Treffer
- opioids 2 Treffer
- pain medicine 2 Treffer
- patients 2 Treffer
- pfizer inc. 2 Treffer
- pharmaceutical policy 2 Treffer
- pharmacodynamics 2 Treffer
- schizophrenia treatment 2 Treffer
- sumitomo dainippon pharma co. ltd. 2 Treffer
- sun pharmaceutical industries ltd. 2 Treffer
- treatment of attention-deficit disorder in adolescence 2 Treffer
- treatment of attention-deficit hyperactivity disorder 2 Treffer
- abbott laboratories inc. 1 Treffer
Sprache
Geographischer Bezug
Inhaltsanbieter
59 Treffer
-
In: PharmaWatch: CNS, Jg. 11 (2012-07-01), Heft 7, S. 30-32reportZugriff:
-
In: PharmaWatch: CNS, Jg. 11 (2012-06-01), Heft 6, S. 24-25reportZugriff:
-
In: PharmaWatch: CNS, Jg. 11 (2012-06-01), Heft 6, S. 23-24reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-12-01), Heft 12, S. 8-9reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-05-01), Heft 5, S. 17-18reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-05-01), Heft 5, S. 2-3reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-04-01), Heft 4, S. 2-3reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-08-01), Heft 8, S. 8-9reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-05-01), Heft 5, S. 11-12reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-05-01), Heft 5, S. 6-7reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-04-01), Heft 4, S. 10-11reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-08-01), Heft 8, S. 8-8reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-07-01), Heft 7, S. 42-48reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-07-01), Heft 7, S. 15-18reportZugriff:
-
In: PharmaWatch: CNS, Jg. 2 (2003-10-01), Heft 10, S. 12-12reportZugriff:
-
In: PharmaWatch: CNS, Jg. 5 (2006), Heft 1, S. 20-26reportZugriff:
-
In: PharmaWatch: CNS, Jg. 3 (2004-11-01), Heft 11, S. 17-23reportZugriff:
-
In: PharmaWatch: CNS, Jg. 11 (2012-07-01), Heft 7, S. 23-25reportZugriff:
-
In: PharmaWatch: CNS, Jg. 11 (2012-07-01), Heft 7, S. 12-14reportZugriff:
-
In: PharmaWatch: CNS, Jg. 10 (2011-07-01), Heft 7, S. 32-34reportZugriff: